Analysed TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
24-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
29-06-2026
yahoo.com
Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling
30-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
30-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading
01-07-2026
yahoo.com
New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring
02-07-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
07-07-2026
yahoo.com
What is the current price of TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ)?
The current price of TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ) is $0.3868.
TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ) absolute price change since previous trading day?
The absolute price change of TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ) since the previous trading day is $-0.0045.
TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ) percentage price change since previous trading day?
The percentage price change of TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ) since the previous trading day is -1.15%.
What is the most recent average sentiment score for TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ)?
The most recent average sentiment score for TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ)?
The most recent sentiment for TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ) is .
SEC-8K** Filing Available For TRINITY BIOTECH PLC-SPON ADR (TRIB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.